See more : NIKE, Inc. (NKE.BA) Income Statement Analysis – Financial Results
Complete financial analysis of Wacker Chemie AG (WKCMF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Wacker Chemie AG, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- Greensmart Corp (GREN) Income Statement Analysis – Financial Results
- Hangzhou Raycloud Technology Co., Ltd. (688365.SS) Income Statement Analysis – Financial Results
- Golden Goliath Resources Ltd. (GGTHF) Income Statement Analysis – Financial Results
- Shyamkamal Investments Limited (SHYMINV.BO) Income Statement Analysis – Financial Results
- West Cobar Metals Limited (WC1.AX) Income Statement Analysis – Financial Results
Wacker Chemie AG (WKCMF)
About Wacker Chemie AG
Wacker Chemie AG, together with its subsidiaries, provides chemical products worldwide. It operates through four divisions: Wacker Silicones, Wacker Polymers, Wacker Biosolutions, and Wacker Polysilicon. The Wacker Silicones division offers silanes, siloxanes, silicone fluids, silicone emulsions, silicone elastomers, silicone resins, and pyrogenic silicas for use in construction, electronics, automotive, health, and renewable energy industries. The Wacker Polymers division provides binders and polymeric additives, such as dispersible polymer powder and vinyl acetate-ethylene dispersions, which are used in construction, paper, adhesive, paint, coating, and basic chemical industries. The Wacker Biosolutions division offers customized biotech and catalog products for fine chemicals, such as pharmaceutical proteins, vaccines, cyclodextrins, cysteine, polyvinyl acetate solid resins, and acetylacetone for pharmaceutical actives, food additives, and agrochemicals. The Wacker Polysilicon division produces hyperpure polysilicon for use in semiconductor and solar sectors. The company was founded in 1914 and is headquartered in Munich, Germany. Wacker Chemie AG is a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.40B | 8.21B | 6.21B | 4.69B | 4.93B | 4.98B | 4.92B | 5.40B | 5.30B | 4.83B | 4.48B | 4.63B | 4.91B | 4.75B | 3.72B | 4.30B | 3.78B | 3.34B | 2.76B | 2.50B |
| Cost of Revenue | 5.32B | 6.05B | 4.54B | 3.82B | 4.12B | 4.10B | 3.97B | 4.41B | 4.17B | 3.98B | 3.82B | 3.82B | 3.75B | 3.40B | 2.88B | 3.11B | -2.63B | -2.38B | -2.11B | -1.98B |
| Gross Profit | 1.08B | 2.16B | 1.67B | 869.90M | 803.20M | 874.70M | 954.40M | 990.70M | 1.13B | 844.20M | 663.50M | 813.10M | 1.16B | 1.35B | 843.50M | 1.19B | 6.41B | 5.71B | 4.86B | 4.49B |
| Gross Profit Ratio | 16.92% | 26.32% | 26.94% | 18.54% | 16.30% | 17.57% | 19.38% | 18.33% | 21.32% | 17.49% | 14.81% | 17.54% | 23.68% | 28.35% | 22.68% | 27.64% | 169.53% | 171.26% | 176.42% | 179.16% |
| Research & Development | 184.10M | 178.40M | 164.20M | 156.60M | 173.30M | 164.60M | 153.10M | 183.40M | 175.30M | 183.10M | 173.80M | 174.50M | 172.90M | 165.10M | 164.00M | 163.20M | -152.50M | -152.30M | -146.90M | -150.60M |
| General & Administrative | 177.50M | 183.20M | 158.80M | 139.50M | 145.60M | 159.70M | 148.50M | 147.30M | 134.00M | 123.70M | 111.70M | 119.20M | 124.00M | 113.30M | 95.50M | 109.50M | 94.10M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 337.50M | 342.50M | 297.60M | 290.60M | 314.50M | 303.50M | 292.40M | 321.60M | 314.20M | 280.60M | 272.00M | 280.20M | 280.80M | 269.60M | 246.40M | 257.60M | -233.50M | -223.90M | -211.20M | -206.10M |
| SG&A | 540.40M | 525.70M | 456.40M | 430.10M | 460.10M | 463.20M | 440.90M | 468.90M | 448.20M | 404.30M | 383.70M | 399.40M | 404.80M | 382.90M | 341.90M | 367.10M | -233.50M | -223.90M | -211.20M | -206.10M |
| Other Expenses | 4.80M | -10.30M | -3.00M | -2.00M | -1.80M | 7.20M | 9.80M | 8.80M | 0.00 | 0.00 | 0.00 | -54.60M | 0.00 | 0.00 | -27.80M | -6.10M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 729.30M | 693.80M | 617.60M | 584.70M | 631.60M | 607.10M | 562.90M | 614.70M | 592.50M | 406.90M | 471.60M | 455.90M | 551.60M | 543.70M | 689.40M | 540.10M | -386.00M | -376.20M | -358.10M | -356.70M |
| Cost & Expenses | 6.05B | 6.74B | 5.15B | 4.41B | 4.76B | 4.71B | 4.53B | 5.03B | 4.76B | 4.39B | 4.29B | 4.28B | 4.30B | 3.95B | 3.57B | 3.65B | -3.02B | -2.75B | -2.46B | -2.34B |
| Interest Income | 48.10M | 10.20M | 6.20M | 8.10M | 10.60M | 8.00M | 7.50M | 6.00M | 7.30M | 8.40M | 15.00M | 16.00M | 16.90M | 7.10M | 6.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 72.60M | 51.10M | 41.80M | 48.90M | 56.80M | 57.50M | 76.90M | 92.40M | 79.70M | 95.80M | 95.30M | 78.40M | 13.50M | 9.10M | 2.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 418.70M | 402.10M | 404.20M | 403.50M | 554.90M | 540.40M | 590.40M | 618.00M | 575.40M | 599.00M | 564.40M | 528.80M | 501.00M | 429.90M | 579.90M | 407.30M | 351.90M | 330.00M | 351.20M | 344.00M |
| EBITDA | 878.30M | 2.07B | 1.54B | 670.30M | 785.30M | 774.80M | 949.40M | 945.40M | 1.06B | 1.06B | 690.70M | 809.00M | 1.08B | 1.17B | 585.20M | 1.06B | 1.00B | 3.08B | 2.82B | 2.68B |
| EBITDA Ratio | 13.72% | 24.90% | 24.61% | 15.39% | 31.15% | 18.58% | 20.40% | 20.09% | 20.00% | 22.25% | 16.29% | 17.46% | 22.04% | 24.67% | 19.73% | 24.55% | 89.05% | 92.43% | 102.16% | 107.14% |
| Operating Income | 353.70M | 1.48B | 1.07B | 318.40M | 215.10M | 257.90M | 379.80M | 365.10M | 470.30M | 440.30M | 150.30M | 340.50M | 580.90M | 764.60M | 26.80M | 647.90M | 651.20M | 458.30M | 254.40M | 99.20M |
| Operating Income Ratio | 5.52% | 17.99% | 17.27% | 6.79% | 4.37% | 5.18% | 7.71% | 6.76% | 8.88% | 9.12% | 3.36% | 7.35% | 11.83% | 16.10% | 0.72% | 15.07% | 17.22% | 13.73% | 9.23% | 3.96% |
| Total Other Income/Expenses | 33.30M | 139.10M | 21.80M | -100.50M | -600.00K | 66.50M | -44.80M | -90.00M | -63.60M | -75.10M | -119.30M | -136.60M | -43.50M | -32.30M | -23.50M | -6.10M | -19.10M | -458.30M | -254.40M | -99.20M |
| Income Before Tax | 387.00M | 1.62B | 1.09B | 217.90M | -591.20M | 324.40M | 335.00M | 264.80M | 406.70M | 365.20M | 31.00M | 193.20M | 567.40M | 732.30M | 3.30M | 641.80M | 632.10M | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 6.04% | 19.69% | 17.62% | 4.64% | -12.00% | 6.52% | 6.80% | 4.90% | 7.68% | 7.57% | 0.69% | 4.17% | 11.56% | 15.42% | 0.09% | 14.93% | 16.72% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 59.70M | 334.60M | 265.80M | 15.60M | 38.40M | 64.30M | 84.90M | 75.50M | 164.90M | 169.80M | 24.70M | 86.40M | 211.30M | 235.30M | 77.80M | -203.50M | 2.59B | 2.44B | 2.32B | 2.32B |
| Net Income | 313.60M | 1.25B | 806.90M | 189.20M | -629.60M | 246.10M | 866.70M | 179.20M | 246.70M | 203.80M | 2.60M | 120.70M | 352.60M | 490.70M | -74.50M | 438.30M | 422.00M | 311.30M | 143.70M | 16.10M |
| Net Income Ratio | 4.90% | 15.24% | 13.00% | 4.03% | -12.78% | 4.94% | 17.60% | 3.32% | 4.66% | 4.22% | 0.06% | 2.60% | 7.18% | 10.33% | -2.00% | 10.20% | 11.16% | 9.33% | 5.21% | 0.64% |
| EPS | 6.31 | 25.18 | 16.24 | 3.81 | -12.67 | 4.95 | 17.45 | 3.61 | 4.97 | 4.10 | 0.05 | 2.43 | 7.10 | 9.88 | -1.50 | 8.84 | 8.49 | 6.46 | 2.90 | 53.31 |
| EPS Diluted | 6.31 | 25.18 | 16.24 | 3.81 | -12.67 | 4.95 | 17.45 | 3.61 | 4.97 | 4.10 | 0.05 | 2.43 | 7.10 | 9.88 | -1.50 | 8.84 | 8.49 | 6.46 | 2.90 | 53.31 |
| Weighted Avg Shares Out | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 44.33M | 52.15M |
| Weighted Avg Shares Out (Dil) | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 49.68M | 44.33M | 52.15M |
Wacker Chemie: Potential Upside Has Now Increased
Wacker Chemie is a chemical company I've been investing in for about a year, that hasn't been reaching its potential yet. However, I believe the company is bound for a reversal, and I think the Q3'24 period/quarter is a good...
Wacker Chemie AG (WKCMF) Q3 2024 Earnings Call Transcript
Wacker Chemie AG (OTC:WKCMF) Q3 2024 Earnings Conference Call October 28, 2024 11:00 AM ET Company Participants Joerg Hoffmann - Head of Investor Relations Christian Hartel - President and Chief Executive Officer Tobias Ohler - Chief Financial Officer Conference Call...
Wacker Chemie AG (WKCMF) Q2 2024 Earnings Call Transcript
Wacker Chemie AG (OTC:WKCMF) Q2 2024 Earnings Conference Call July 26, 2024 10:00 AM ET Company Participants Joerg Hoffmann - Head of IR Christian Hartel - CEO Tobias Ohler - CFO Conference Call Participants Rikin Patel - BNB Andreas Heine...
Wacker Chemie: Maintaining My Position For The Long Haul
Wacker Chemie is expected to see near-term declines due to negative earnings trends and a decline in adjusted EPS. The company remains solid with strong sales and a focus on specialty silicones, biotechnology, and advanced medicine. Despite the current financial...
Wacker Chemie AG (WKCMF) Q1 2024 Earnings Call Transcript
Wacker Chemie AG (OTC:WKCMF) Q1 2024 Results Conference Call April 25, 2024 10:00 AM ET Company Participants Joerg Hoffmann - Head of Investor Relations Christian Hartel - CEO, President & Member of Executive Board Tobias Ohler - CFO & Member...
Wacker Chemie AG (WKCMF) Q4 2023 Earnings Call Transcript
Wacker Chemie AG (WKCMF) Q4 2023 Earnings Call Transcript
Wacker Chemie: Finally Getting More Attractive
Wacker Chemie has experienced a significant decline in its stock price and a negative return on investment. Despite the downturn, I remain confident in the company's long-term prospects and recommend considering it for investment. The company's sales have decreased, but...
Wacker Chemie AG (WKCMF) Q3 2023 Earnings Call Transcript
Wacker Chemie AG (WKCMF) Q3 2023 Earnings Call Transcript
Wacker Chemie: You Should Put This Company On Your Watchlist
Wacker Chemie is a leading company in the chemicals sector with a solid history and attractive mix of materials. Despite challenges in the current macro environment, the company remains profitable and focused on growth areas. The company's valuation is currently...
Wacker Chemie AG (WKCMF) Q2 2023 Earnings Call Transcript
Wacker Chemie AG (OTC:WKCMF) Q2 2023 Earnings Conference Call July 27, 2023 10:00 AM ET Company Participants Joerg Hoffmann - Head of Investor Relations Christian Hartel - Chief Executive Officer Tobias Ohler - Chief Financial Officer Conference Call Participants Matthew...
Source: https://incomestatements.info
Category: Stock Reports